You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Harvard Business School
Mallinckrodt
Medtronic
Boehringer Ingelheim

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 6,491,623

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,491,623
Title: Device for preventing fecal incontinence
Abstract:An implantable device for controlling a body conduit including a cuff portion adapted to substantially encircle a body conduit. An inlet tube is operatively connected for delivering fluid to the cuff portion. The inlet tube has a one-way valve. An outlet tube is operatively connected to the cuff portion for releasing fluid therefrom and includes a normally closed valve. A pumping reservoir is in communication with the inlet tube and the outlet tube, wherein manipulation of the pumping reservoir inflates the cuff portion and manipulation of the normally closed valve deflates the cuff portion. An inflatable lumen surrounds the pumping reservoir and the cuff portion to provide rigidity and balance pressure between the cuff portion and the pumping reservoir.
Inventor(s): Snyder; Daniel R. (Branford, CT), Fellows; Harriet A. (Haddam, CT)
Assignee: Harridan Medical (Branford, CT)
Application Number:09/769,504
Patent Claims:see list of patent claims

Details for Patent 6,491,623

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Harridan Medical (Branford, CT) 2020-01-25 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Harridan Medical (Branford, CT) 2020-01-25 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Mallinckrodt
Harvard Business School
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.